*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Troubled construction company Kier said full year underlying operating profit would be £25m lower than previous expectations with higher net debts and flat revenue.
The Renewables Infrastructure Group (TRIG) on Monday said it was buying a 25% indirect stake in Gode Wind 1, a 330MW offshore wind farm located in the German North Sea, for an undisclosed sum.
AstraZeneca announced on Monday that its Lynparza pancreatic cancer drug has returned positive phase three trial results, doubling the amount of patients with no disease progression.
Smith & Nephew on Monday completed its acquisition of orthopaedic joint reconstruction outfit Brainlab, whose digital workflow technology is used by surgeons in more than 500 hospitals worldwide.
